Imedex®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Imedex, LLC designates this live educational activity for a maximum 7.0 of AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Who Should Attend
This online educational activity is specifically designed for hematologists, oncologists, and other health-care professionals (physicians, physicians-in-training, oncology nurses, pharmacists, physicians' assistants, etc.) involved and/or interested in the therapeutic management of patients with hematologic malignancies and benign hematologic conditions.
Objectives
After successfully completion of this course, participants should be able to have:
- Increased awareness of clinical advances in hematology and their potential impact on current practice
- Increased awareness of new insights into the genetics and molecular biology of malignant and benign hematologic conditions, and how these findings are being used to develop novel prognostic and therapeutic strategies
- Increased confidence in ability to evaluate the potential benefits and risks of novel therapies for malignant and benign hematologic conditions and navigate practical issues in incorporating these agents into patient care
- Increased frequency of plans to incorporate practice-changing new data, when appropriate, into treatment decisions for patients with malignant or benign hematologic conditions
7:00 am
Breakfast buffet and registration
8:00 am
Welcome and introduction
8:15 am
Multiple Myeloma
9:00 am
Q & A and critical assessment of audience response to case
9:15 am
Chronic Lymphocytic Leukemia
9:45 am
Q & A and critical assessment of audience response to case
10:00 am
Break
10:30 am
Myeloproliferative Neoplasms
11:00 am
Q & A and critical assessment of audience response to case
11:15 am
Lymphoma
12:00 pm
Q & A and critical assessment of audience response to case
12:15 pm
Lunch
1:30 pm
Chronic Myelogenous Leukemia
2:10 pm
Q & A and critical assessment of audience response to case
2:25 pm
Myelodysplastic Syndromes
2:55 pm
Q & A and critical assessment of audience response to case
3:10 pm
Break
3:30 pm
Acute Leukemia
4:00 pm
Q & A and critical assessment of audience response to case
4:15 pm
Benign Hematology
4:45 pm
Q & A and critical assessment of audience response to case
5:00 pm
Adjourn
Early
Payment received by November 21, 2011 |
$79.00 |
Discounted
Payment received by January 16, 2012 |
$99.00 |
Regular
If payment received after January 16, 2012 |
$129.00 |
Group with Discounted Fees:
Nurses/Students/Residents *
*Proof of eligibility must accompany registration; cannot be combined with any other discounts. |
$55.00 |
To Register: You may register by January 16, 2012 by emailing imedex at registration@imedex.com, calling Imedex at +1 (855) 276 6855 or by returning the registration form in this program by mail or fax at +1 (678) 242 0920. If you mail the form, please keep a copy for your records. Registration confirmations will be issued before the meeting.
To qualify for special registration fees, registration and full payment must be received by Imedex by the dates specified.
Payment: To pre-register, registration and payment must be received no later than January 16, 2012. Please register onsite after this date. Contact Imedex at +1 (855) 276 6855 or visit our website at www.imedex.com to ensure the course is being held as scheduled and to confirm that the meeting is not full.
Registration fees must be remitted by credit card or check. Checks should be payable to Imedex. Attendee is not registered until full payment is received.
Registration Fee Inclusions: Registration fees include admittance to all scientific sessions, conference materials, processing of certificates of attendance or continuing medical education, and all event functions as specified in the agenda.
Cancellation: For registration fees to be refunded, written notice of cancellation must be received at registration@imedex.com no later than January 16, 2012. The amount of registration fees remitted, minus a $75 administrative charge, will be refunded after the conference. Substitutions are accepted with written notification. No refunds will be made if notice is received after January 16, 2012.
Imedex does not accept responsibility for covering travel, accommodation or any other costs incurred by registrants in the rare event that this meeting should be canceled for any reason. Every effort will be made to give reasonable notice in the event of cancellation. The event agenda is subject to change without notice.
Audience Participation...
A Hands-On Experience
During the scientific sessions, speakers and the audience can exchange information through a "hands-on" computerized speaker-audience interaction system. With this state-of-the-art equipment, participants answer multiple choice questions, and within seconds, the answers are calculated and projected on a screen in tabular or graphic form for all to see. This system maximizes the ability for attendees from diverse disciplines to see differing opinions and compare consensus between the speakers and each other.
Organizer
Imedex
11675 Rainwater Drive, Suite 600
Alpharetta, GA 30009, USA
Tel.: +1 (770) 751 7332
Fax: +1 (770) 751 7334
Email: meetings@imedex.com
Web: www.imedex.com
For registration inquiries:
Tel.: +1 855-276-6855
Email: registration@imedex.com
Important Dates
Early Registration Deadline
November 21, 2011
Discounted Registration Deadline
January 16, 2012
Presentation Dates
January 21, 2012
Imedex is a brand and assumed name used by Imedex, LLC (hereby referred to as Imedex). Imedex is solely responsible for this agenda’s content. Although Imedex attempts to ensure that the information in our program is accurate and timely, matters and opinions discussed and/or presented with respect to clinical matters are those of the discussion participants only, and not necessarily those of Imedex. Moreover, although Imedex attempts to identify and integrate the most qualified medical professionals in our program, TO THE FULLEST EXTENT PERMITTED BY LAW, IMEDEX EXPRESSLY DISCLAIM ALL WARRANTIES, EITHER EXPRESS OR IMPLIED, STATUTORY OR OTHERWISE, INCLUDING BUT NOT LIMITED TO THE IMPLIED WARRANTIES OF MERCHANTABILITY, NON-INFRINGEMENT OF THIRD PARTIES’ RIGHTS, AND FITNESS FOR A PARTICULAR PURPOSE, WITH RESPECT TO THE CONTENT PRESENTED. IMEDEX FURTHER MAKES NO REPRESENTATIONS OR WARRANTIES ABOUT THE ACCURACY, RELIABILITY, COMPLETENESS OR TIMELINESS OF THE CONTENT OR ANY MATERIAL PRESENTED.
In addition, the material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a physician-patient relationship. Medical advice of any nature should be sought from an individual’s own physician.
Neither Imedex nor any of its subsidiaries or affiliates is affiliated with or formally endorsed by a medical society.
©2011 Imedex®, LLC. All rights reserved.
Reproduction in whole or part is prohibited without prior written consent from Imedex and contributing faculty.
Information coming soon.
Several options are available to companies interested in supporting this conference.
For more information, please contact Imedex at +1 (770) 751 7332, or by email at cme@imedex.com.
Exhibit space is available to companies interested in participating in this conference through exhibition. For more information, please contact Imedex at +1 (678) 242 0719 or by email at exhibits@imedex.com.
